Generation of human melanocytes from induced pluripotent stem cells

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Ohta, Shigeki ^a   Imaizumi, Yoichi ^a   Okada, Yohei ^a   Akamatsu, Wado ^a   Kuwahara, Reiko ^a   Ohyama, Manabu ^a   Amagai, Masayuki ^a   Matsuzaki, Yumi ^a   Yamanaka, Shinya ^b,c   Okano, Hideyuki ^a   Kawakami, Yutaka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CELL PROTEIN; KRUPPEL LIKE FACTOR 4; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN ET 3; PROTEIN SCF; PROTEIN SILV; PROTEIN TYRP1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; WNT3A PROTEIN; DNA BINDING PROTEIN; KRUPPEL LIKE FACTOR; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EMBRYOID BODY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOCYTE; MELANOSOME; PIGMENT CELL; PLURIPOTENT STEM CELL; PREPUCE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; METHODOLOGY; SKIN;

IPS;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; EMBRYOID BODIES; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MELANOCYTES; OCTAMER TRANSCRIPTION FACTOR-3; SKIN; SOXB1 TRANSCRIPTION FACTORS;

EID: 79251578074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016182     Document Type: Article

References (42)

1. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16: 208-214.
2. Czajkowski R, Placek W, Drewa T, Kowaliszyn B, Sir J, et al. (2007) Autologous cultured melanocytes in vitiligo treatment. Dermatol Surg 33: 1027-1036; discussion 1035-1026.
3. van Geel N, Ongenae K, Naeyaert JM (2001) Surgical techniques for vitiligo: a review. Dermatology 202: 162-166.
4. Grichnik JM (2008) Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol 128: 2365-2380.
5. Schatton T, Frank MH (2008) Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 21: 39-55.
6. Sabatino M, Stroncek DF, Klein H, Marincola FM, Wang E (2009) Ste m cells inmelanoma development. Cancer Lett 279: 119-125.
7. Nishimura EK, Granter SR, Fisher DE (2005) Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307: 720-724.
8. Osawa M, Egawa G, Mak SS, Moriyama M, Freter R, et al. (2005) Molecular characterization of melanocyte stem cells in their niche. Development 132: 5589-5599.
9. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337.
10. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, et al. (2007) Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43: 935-946.
11. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, et al. (2008) Identification of cells initiating human melanomas. Nature 451: 345-349.
12. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133-137.
13. Levy C, Khaled M, Fisher DE (2006) MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12: 406-414.
14. Fang D, Leishear K, Nguyen TK, Finko R, Cai K, et al. (2006) Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells 24: 1668-1677.
15. Yamane T, Hayashi S, Mizoguchi M, Yamazaki H, Kunisada T (1999) Derivation of melanocytes from embryonic stem cells in culture. Dev Dyn 216: 450-458.
16. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221.
17. Ebert AD, Yu J, Rose FF, Jr., Mattis VB, Lorson CL, et al. (2009) Induced pluripotent stem cells from a spinalmuscular atrophy patient. Nature 457: 277-280.
18. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, et al. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patientspecific iPSCs. Nature 461: 402-406.
19. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, et al. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964-977.
20. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
21. White RM, Zon LI (2008) Melanocytes in development, regeneration, and cancer. Cell Stem Cell 3: 242-252.
22. Abbas O, Mahalingam M (2009) Epidermal stem cells: practical perspectives and potential uses. Br J Dermatol 161: 228-236.
23. Lang D, Lu MM, Huang L, Engleka KA, Zhang M, et al. (2005) Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433: 884-887.
24. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106.
25. Nishimura EK, Suzuki M, Igras V, Du J, Lonning S, et al. Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell 6: 130-140.
26. Li L, Fukunaga-Kalabis M, Yu H, Xu X, Kong J, et al. Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci 123: 853-860.
27. Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, et al. (2008) Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet 40: 1291-1299.
28. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, et al. (2004) Defining the epithelial stem cell niche in skin. Science 303: 359-363.
29. Amoh Y, Li L, Katsuoka K, Penman S, Hoffman RM (2005) Multipotent nestinpositive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci U S A 102: 5530-5534.
30. Yu H, Kumar SM, Kossenkov AV, Showe L, Xu X Stem cells with neural crest characteristics derived from the bulge region of cultured human hairfollicles. J Invest Dermatol 130: 1227-1236.
31. Toma JG, McKenzie IA, Bagli D, Miller FD (2005) Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23: 727-737.
32. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284.
33. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, et al. Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized. Cancer Cell 18: 510-523.
34. Zabierowski SE, Herlyn M (2008) Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 26: 2890-2894.
35. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, et al. (2009) Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27: 743-745.
36. Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A 107: 14152-14157.
37. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275-280.
38. Lin JY, Fisher DE (2007) Melanocyte biology and skin pigmentation. Nature 445: 843-850.
39. Steingrimsson E, Copeland NG, Jenkins NA (2004) Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38: 365-411.
40. Kiskinis E, Eggan K Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120: 51-59.
41. Suemori H, Yasuchika K, Hasegawa K, Fujioka T, Tsuneyoshi N, et al. (2006) Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun 345: 926-932.
42. Freberg CT, Dahl JA, Timoskainen S, Collas P (2007) Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol Biol Cell 18: 1543-1553.